Status:
UNKNOWN
Comparing Sevoflurane With Propofol Sedation in ESRF Patients
Lead Sponsor:
University of Malaya
Conditions:
Sevoflurane
Kidney Diseases
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
End-stage renal failure (ESRF) cohorts undergo brachiocephalic fistula(BCF) transposition with supraclavicular block. However, this is inadequate because the incision may extend to the axillary region...
Detailed Description
Regional anesthesia has been shown to be superior to general anesthesia in end-stage renal disease (ESRF) patients undergoing brachiocephalic transposition by ensuring graft patency, reducing pharmaco...
Eligibility Criteria
Inclusion
- Patient with end stage renal failure, dialysis dependent undergoing transposition of brachiocephalic fistula repair
- American Society of Anesthesiology Physical Status Classification System (ASA) II or III
Exclusion
- Patient refusal
- History or family history of malignant hyperthermia
- Known allergy to propofol or local anaesthetic agent
- Patients who have taken neuroleptics, benzodiazepine over 2 weeks within 1 month
- Chronic use of alcohols/ opioid
- Active lungs disease (eg. acute exacerbation of chronic obstructive pulmonary disease)
- Active and significant cardiac disease (eg. decompensated congestive cardiac failure, recent myocardial infarction)
- End-stage heart failure with left ventricular ejection fraction \< 30%
- Recent (\< 3 months) cerebrovascular accident
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2022
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04839536
Start Date
April 1 2021
End Date
April 30 2022
Last Update
April 9 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.